Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Etrych

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2023
Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activationM Kovář, V Šubr, K Běhalová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Journal of Materials Chemistry. B|April 9, 2020
PCL-PEG graft copolymers with tunable amphiphilicity as efficient drug delivery systemsA Al Samad, A Bethry, E Koziolová, et al.
Journal of Materials Chemistry. B|April 9, 2020
Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulationE Koziolová, D Machová, R Pola, et al.
Nanoscale|July 14, 2017
Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicinY Chen, O Tezcan, D Li, et al.
Gene Therapy|July 1, 2006
Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNAR C Carlisle, S S Briggs, A B Hale, et al.
Journal of Nanobiotechnology|September 22, 2018
Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3P Bojarová, M R Tavares, D Laaf, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2023
Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activationM Kovář, V Šubr, K Běhalová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Journal of Materials Chemistry. B|April 9, 2020
PCL-PEG graft copolymers with tunable amphiphilicity as efficient drug delivery systemsA Al Samad, A Bethry, E Koziolová, et al.
Journal of Materials Chemistry. B|April 9, 2020
Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulationE Koziolová, D Machová, R Pola, et al.
Nanoscale|July 14, 2017
Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicinY Chen, O Tezcan, D Li, et al.
Gene Therapy|July 1, 2006
Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNAR C Carlisle, S S Briggs, A B Hale, et al.
Journal of Nanobiotechnology|September 22, 2018
Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3P Bojarová, M R Tavares, D Laaf, et al.
Pageof 4